Global Mesenchymal Stem Cells Market by Manufacturers, Regions, Type and Application, Forecast to 2022


Report ID : RNR-90278 Category : Biotechnology Published Date : 23-May-17
Publisher : GlobalInfo Research Pages : 120 Format : PDF
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal.

Scope of the Report:
This report focuses on the Mesenchymal Stem Cells in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers 
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience

Market Segment by Regions, regional analysis covers 
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Australia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, Argentina, UAE and South Africa)

Market Segment by Type, covers
Human MSC
Mouse MSC
Rat MSC
Other

Market Segment by Applications, can be divided into
Research Institute
Hospital
Others

There are 15 Chapters to deeply display the global Mesenchymal Stem Cells market.

Chapter 1, to describe Mesenchymal Stem Cells Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Mesenchymal Stem Cells, with sales, revenue, and price of Mesenchymal Stem Cells, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Mesenchymal Stem Cells, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Mesenchymal Stem Cells market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Mesenchymal Stem Cells sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents

1.1 Mesenchymal Stem Cells Introduction	1
1.2 Market Analysis by Type	2
1.2.1 Human MSC	4
1.2.2 Mouse MSC	4
1.2.3 Rat MSC	5
1.2.4 Rabbit MSC	5
1.3 Market Analysis by Applications	6
1.4 Market Analysis by Regions	7
1.4.1 North America (USA, Canada and Mexico)	7
1.4.1.1 USA Market States and Outlook (2012-2022)	7
1.4.1.2 Canada Market States and Outlook (2012-2022)	8
1.4.1.3 Mexico Market States and Outlook (2012-2022)	9
1.4.2 Europe (Germany, France, UK, Russia and Italy)	10
1.4.2.1 Germany Market States and Outlook (2012-2022)	10
1.4.2.2 France Market States and Outlook (2012-2022)	11
1.4.2.3 UK Market States and Outlook (2012-2022)	12
1.4.2.4 Russia Market States and Outlook (2012-2022)	13
1.4.2.5 Italy Market States and Outlook (2012-2022)	14
1.4.3 Asia-Pacific (China, Japan, Korea, India and Australia)	15
1.4.3.1 China Market States and Outlook (2012-2022)	15
1.4.3.2 Japan Market States and Outlook (2012-2022)	16
1.4.3.3 Korea Market States and Outlook (2012-2022)	17
1.4.3.4 India Market States and Outlook (2012-2022)	18
1.4.3.5 Australia Market States and Outlook (2012-2022)	19
1.4.4 South America, Middle East and Africa	20
1.4.4.1 Brazil Market States and Outlook (2012-2022)	20
1.4.4.2 Argentina Market States and Outlook (2012-2022)	21
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)	22
1.4.4.4 South Africa Market States and Outlook (2012-2022)	23
1.4.4.5 UAE Market States and Outlook (2012-2022)	24
1.5 Market Dynamics	24
1.5.1 Market Opportunities	24
1.5.2 Market Risk	25
1.5.3 Market Driving Force	25
2 Analysis of Mesenchymal Stem Cells Industry Key Manufacturers	26
2.1 Lonza	26
2.1.1 Company Profile	26
2.1.2 Product Information	27
2.1.3 Sales, Price, Cost, Gross, and Revenue	28
2.2 Thermo Fisher	28
2.2.1 Company Profile	28
2.2.2 Product Information	29
2.2.3 Sales, Price, Cost, Gross, and Revenue	30
2.3 Bio-Techne	30
2.3.1 Company Profile	30
2.3.2 Product Information	31
2.3.3 Sales, Price, Cost, Gross, and Revenue	32
2.4 ATCC	32
2.4.1 Company Profile	32
2.4.2 Product Information	33
2.4.3 Sales, Price, Cost, Gross, and Revenue	34
2.5 MilliporeSigma	34
2.5.1 Company Profile	34
2.5.2 Product Information	35
2.5.3 Sales, Price, Cost, Gross, and Revenue	36
2.6 PromoCell GmbH	36
2.6.1 Company Profile	36
2.6.2 Product Information	37
2.6.3 Sales, Price, Cost, Gross, and Revenue	37
2.7 Genlantis	38
2.7.1 Company Profile	38
2.7.2 Product Information	39
2.7.3 Sales, Price, Cost, Gross, and Revenue	39
2.8 Celprogen	40
2.8.1 Company Profile	40
2.8.2 Product Information	41
2.8.3 Sales, Price, Cost, Gross, and Revenue	41
2.9 Cell Applications	42
2.9.1 Company Profile	42
2.9.2 Product Information	43
2.9.3 Sales, Price, Cost, Gross, and Revenue	44
2.10 Cyagen Biosciences	44
2.10.1 Company Profile	44
2.10.2 Product Information	45
2.10.3 Sales, Price, Cost, Gross, and Revenue	46
2.11 Axol Bioscience	46
2.11.1 Company Profile	46
2.11.2 Product Information	47
2.11.3 Sales, Price, Cost, Gross, and Revenue	48
3 Global Mesenchymal Stem Cells Market Competition, by Manufacturer	48
3.1 Global Mesenchymal Stem Cells Sales and Market Share by Manufacturer	48
3.2 Global Mesenchymal Stem Cells Revenue and Market Share by Manufacturer	50
3.3 Market Concentration Rate	53
3.3.1 Top 3 Mesenchymal Stem Cells Manufacturer Market Share	53
3.3.2 Top 6 Mesenchymal Stem Cells Manufacturer Market Share	54
3.4 Market Competition Trend	55
4 Global Mesenchymal Stem Cells Market Analysis by Regions	56
4.1 Global Mesenchymal Stem Cells Sales, Sales Revenue and Market Share by Regions	56
4.1.1 Global Mesenchymal Stem Cells Sales by Regions (2012-2017)	57
4.1.2 Global Mesenchymal Stem Cells Sales Revenue by Regions (2012-2017)	58
4.2 North America Mesenchymal Stem Cells Sales and Growth (2012-2017)	60
4.3 Europe Mesenchymal Stem Cells Sales and Growth (2012-2017)	61
4.4 Asia-Pacific Mesenchymal Stem Cells Sales and Growth (2012-2017)	62
4.5 South America Mesenchymal Stem Cells Sales and Growth (2012-2017)	63
4.6 Middle East and Africa Mesenchymal Stem Cells Sales and Growth (2012-2017)	64
5 North America Mesenchymal Stem Cells by Countries	65
5.1 North America Mesenchymal Stem Cells Sales, Sales Revenue and Market Share by Countries	65
5.1.1 North America Mesenchymal Stem Cells Sales by Countries (2012-2017)	65
5.1.2 North America Mesenchymal Stem Cells Sales Revenue by Countries (2012-2017)	67
5.2 USA Mesenchymal Stem Cells Sales and Growth (2012-2017)	70
5.3 Canada Mesenchymal Stem Cells Sales and Growth (2012-2017)	71
5.4 Mexico Mesenchymal Stem Cells Sales and Growth (2012-2017)	72
6 Europe Mesenchymal Stem Cells by Countries	73
6.1 Europe Mesenchymal Stem Cells Sales, Sales Revenue and Market Share by Countries	73
6.1.1 Europe Mesenchymal Stem Cells Sales by Countries (2012-2017)	73
6.1.2 Europe Mesenchymal Stem Cells Sales Revenue by Countries (2012-2017)	75
6.2 Germany Mesenchymal Stem Cells Sales and Growth (2012-2017)	78
6.3 UK Mesenchymal Stem Cells Sales and Growth (2012-2017)	79
6.4 France Mesenchymal Stem Cells Sales and Growth (2012-2017)	80
6.5 Russia Mesenchymal Stem Cells Sales and Growth (2012-2017)	81
6.6 Italy Mesenchymal Stem Cells Sales and Growth (2012-2017)	82
7 Asia-Pacific Mesenchymal Stem Cells by Countries	83
7.1 Asia-Pacific Mesenchymal Stem Cells Sales, Sales Revenue and Market Share by Countries	83
7.1.1 Asia-Pacific Mesenchymal Stem Cells Sales by Countries (2012-2017)	83
7.1.2 Asia-Pacific Mesenchymal Stem Cells Sales Revenue by Countries (2012-2017)	85
7.2 China Mesenchymal Stem Cells Sales and Growth (2012-2017)	88
7.3 Japan Mesenchymal Stem Cells Sales and Growth (2012-2017)	89
7.4 Korea Mesenchymal Stem Cells Sales and Growth (2012-2017)	90
7.5 India Mesenchymal Stem Cells Sales and Growth (2012-2017)	91
7.6 Australia Mesenchymal Stem Cells Sales and Growth (2012-2017)	92
8 South America Mesenchymal Stem Cells by Countries	93
8.1 South America Mesenchymal Stem Cells Sales, Sales Revenue and Market Share by Countries	93
8.1.1 South America Mesenchymal Stem Cells Sales by Countries (2012-2017)	93
8.1.2 South America Mesenchymal Stem Cells Sales Revenue by Countries (2012-2017)	95
8.2 Brazil Mesenchymal Stem Cells Sales and Growth (2012-2017)	98
8.3 Argentina Mesenchymal Stem Cells Sales and Growth (2012-2017)	99
9 Middle East and Africa Mesenchymal Stem Cells by Countries	100
9.1 Middle East and Africa Mesenchymal Stem Cells Sales, Sales Revenue and Market Share by Countries	100
9.1.1 Middle East and Africa Mesenchymal Stem Cells Sales by Countries (2012-2017)	100
9.1.2 Middle East and Africa Mesenchymal Stem Cells Sales Revenue by Countries (2012-2017)	102
9.2 Saudi Arabia Mesenchymal Stem Cells Sales and Growth (2012-2017)	105
9.3 UAE Mesenchymal Stem Cells Sales and Growth (2012-2017)	106
9.4 South Africa Mesenchymal Stem Cells Sales and Growth (2012-2017)	107
10 Global Mesenchymal Stem Cells Market Segment by Type	108
10.1 Global Mesenchymal Stem Cells Sales, Sales Revenue and Market Share by Type (2012-2017)	108
10.1.1 Global Mesenchymal Stem Cells Sales and Market Share by Type (2012-2017)	108
10.1.2 Global Mesenchymal Stem Cells Sales Revenue and Market Share by Type (2012-2017)	108
10.2 Human MSC Sales Growth and Price	109
10.2.1 Global Human MSC Sales Growth (2012-2017)	109
10.2.2 Global Human MSC Sales Price (2012-2017)	110
10.3 Mouse MSC Sales Growth and Price	111
10.3.1 Global Mouse MSC Sales Growth (2012-2017)	111
10.3.2 Global Mouse MSC Sales Price (2012-2017)	112
10.4 Rat MSC Sales Growth and Price	113
10.4.1 Global Rat MSC Sales Growth (2012-2017)	113
10.4.2 Global Rat MSC Sales Price (2012-2017)	114
10.5 Other MSC Sales Growth and Price	115
10.5.1 Global Other MSC Sales Growth (2012-2017)	115
10.5.2 Global Other MSC Sales Price (2012-2017)	116
11 Global Mesenchymal Stem Cells Market Segment by Application	116
11.1 Global Mesenchymal Stem Cells Sales Market Share by Application (2012-2017)	116
11.2 Research Institute Sales Growth (2012-2017)	117
11.3 Hospital Sales Growth (2012-2017)	118
11.4 Others Sales Growth (2012-2017)	119
12 Mesenchymal Stem Cells Market Forecast (2017-2022)	120
12.1 Global Mesenchymal Stem Cells Sales, Revenue and Growth Rate (2017-2022)	120
12.2 Mesenchymal Stem Cells Market Forecast by Regions (2017-2022)	121
12.2.1 North America Mesenchymal Stem Cells Market Forecast (2017-2022)	122
12.2.2 Europe Mesenchymal Stem Cells Market Forecast (2017-2022)	123
12.2.3 Asia-Pacific Mesenchymal Stem Cells Market Forecast (2017-2022)	124
12.2.4 South America Mesenchymal Stem Cells Market Forecast (2017-2022)	125
12.2.5 Middle East and Africa Mesenchymal Stem Cells Market Forecast (2017-2022)	126
12.3 Mesenchymal Stem Cells Market Forecast by Type (2017-2022)	126
12.4 Mesenchymal Stem Cells Market Forecast by Application (2017-2022)	127
13 Sales Channel, Distributors, Traders and Dealers	128
13.1 Sales Channel	128
13.1.1 Direct Marketing	128
13.1.2 Indirect Marketing	128
13.1.3 Marketing Channel Future Trend	128
13.2 Distributors, Traders and Dealers	129
14 Research Findings and Conclusion	130
15 Appendix	131
15.1 Methodology	131
15.2 Data Source	132